当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Antonio Caruso
Bacteriophages, or phages, are viruses that specifically infect and kill bacteria. In the face of rising antibiotic resistance, there is a resurgence of interest in phage therapy as a contemporary approach to combat infectious diseases. This article explores the applications of bacteriophages in treating infectious diseases, emphasizing their targeted precision, personalized medicine potential, and effectiveness against antibiotic-resistant bacteria. Phage therapy's ability to disrupt bacterial biofilms and its real-world success stories are also discussed. Challenges and future directions, including regulatory considerations and the need for a deeper understanding of phage biology, are highlighted. Bacteriophages offer a promising avenue for the treatment of infectious diseases, presenting an alternative to conventional antibiotics, especially in the era of antibiotic resistance.